Login / Signup

The comparison of clinical, laboratory, and radiological findings in immunocompromised and immunocompetent patients with COVID-19: A case-control study.

Ladan AbasianFatemeh JafariSeyedAhmad SeyedAlinaghiNiloofar Ayoobi YazdiMorteza DaraeiNasrin AhmadinejadFereshteh GhiasvandHosein KhaliliArash SeifiMohsen MaydaniFarzane BehnezhadZahra Ahmadinejad
Published in: Immunity, inflammation and disease (2023)
Recovery time was significantly longer in the immunocompromised compared to the immunocompetent group, which emphasizes the necessity of prolonged care in these high-risk patients. Also, it is recommended to investigate the effect of novel therapeutic interventions to reduce the recovery time in addition to improving the prognosis of immunodeficient patients with COVID-19.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • healthcare
  • newly diagnosed
  • chronic kidney disease
  • quality improvement
  • respiratory failure
  • patient reported outcomes
  • pain management
  • patient reported
  • health insurance